Skip to main content
. 2010 Jan 8;95(2):567–577. doi: 10.1210/jc.2009-1611

Table 2.

Change in body composition and cardiovascular risk marker variables with treatment

Placebo
GH
P value comparing baseline between groups P value comparing change at 6 months between groups
Baseline Change Baseline Change
Total body fat (kg) 32.3 ± 12.0 0.7 ± 2.2 29.9 ± 9.2 −1.6 ± 3.2 0.54 0.04
Total abdominal fat (mm2) 46949 ± 16674 1164 ± 4319 47654 ± 12725 −4434 ± 7684 0.91 0.04
Subcutaneous adipose tissue (mm2) 30778 ± 13304 1288 ± 4257 33447 ± 11047 −2430 ± 5247 0.57 0.06
Visceral adipose tissue (mm2) 19006 ± 9922 540 ± 2401 14207 ± 6730 −2004 ± 3515 0.14 0.03
Total fat-free mass (kg) 59.9 ± 17.1 −0.1 ± 1.9 58.7 ± 13.4 1.5 ± 1.4 0.84 0.02
Total body water (kg) 47.5 ± 16.5 −0.8 ± 4.4 43.85 ± 9.7 1.4 ± 2.1 0.49 0.13
Resting energy expenditure (kcal) 1665.6 ± 351.9 −24.9 ± 229.5 1513.1 ± 256.9 146.9 ± 163.5 0.21 0.04
Mean arterial pressure (mm Hg) 91.1 ± 8.0 −2.2 ± 7.8 89.1 ± 7.7 −1.4 ± 7.9 0.50 0.80
Total cholesterol (mg/dl) 196 ± 28 −9 ± 22 189 ± 44 −8 ± 18 0.61 0.93
HDL (mg/dl) 46 ± 14 −8 ± 11 53 ± 13 −8 ± 9 0.15 0.91
LDL (mg/dl) 125 ± 27 −4 ± 20 119 ± 37 −3 ± 18 0.62 0.90
Triglycerides (mg/dl) 127 ± 39 17 ± 53 86 ± 32 17 ± 29 0.004 0.98
hsCRP (mg/liter) 3.23 ± 2.42 1.64 ± 3.36 2.93 ± 3.32 −0.36 ± 1.52 0.78 0.05
Mean IMT (mm) 0.65 ± 0.12 −0.008 ± 0.03 0.66 ± 0.16 0.008 ± 0.05 0.81 0.32
Fibrinogen (mg/dl) 306 ± 60 13 ± 74 339 ± 68 −19 ± 62 0.91 0.24
Fasting glucose (mg/dl) 87 ± 11 1 ± 10 83 ± 7 2 ± 10 0.26 0.91
Fasting insulin (μIU/ml) 9.70 ± 6.54 2.08 ± 2.57 10.28 ± 4.67 3.47 ± 10.17 0.79 0.62
HOMA-IR 2.16 ± 1.61 0.49 ± 0.63 2.23 ± 0.97 0.89 ± 2.68 0.89 0.59
Hemoglobin A1c (%) 5.79 ± 0.50 0.03 ± 0.35 5.49 ± 0.35 0.19 ± 0.36 0.07 0.23

Data are presented mean ± sd. Mean arterial pressure = diastolic blood pressure + 1/3 (systolic blood pressure − diastolic blood pressure). Significant P values are bolded